Clinical activity of P-BCMA-ALLO1, a B-cell maturation antigen (BCMA) targeted allogeneic chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed refractory multiple myeloma (RRMM) patients (pts) following progression on prior BCMA targeting therapy

被引：2
|
作者：
Dholaria, Bhagirathbhai
Shune, Leyla
Kin, Andrew
McArthur, Katherine
Eskew, Jeff D.
Martin, Christopher E.
Haag, Sabrina
McCaigue, Joanne
Namini, Hamid
DePrimo, Sam
Cranert, Stacey
Coronella, Julia
Shedlock, Devon
Belani, Rajesh
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT071
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
  • [42] Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
    Ababneh, Hazim S.
    Yee, Andrew J.
    Raje, Noopur S.
    Martin, Sidney
    Frigault, Matthew J.
    Ng, Andrea K.
    Patel, Chirayu G.
    RADIOTHERAPY AND ONCOLOGY, 2023, 189
  • [43] Role of B-Cell Maturation Antigen (BCMA) Targeted Immunotherapies in Relapsed and Refractory Multiple Myeloma- a Systematic Review
    Shah, Zunairah
    Batool, Syeda Sabeeka
    Fazeel, Hafiz Muhammad
    Malik, Mustafa Nadeem
    Sadiq, Maryam
    Hassan, Syeda Fatima
    Syed, Tariq Iqtidar Sadiq
    Abdullah, Syed Maaz
    Javed, Nisma
    Ashraf, Aqsa
    Farooqui, Arafat Ali Ali
    Yousaf, Muhammad Abdullah
    Ahmad, Muhaddis Ejaz
    Ghani, Marium
    Akbar, Arshia
    Anwer, Faiz
    BLOOD, 2019, 134
  • [44] Updated results from CARTITUDE-1: Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T (CAR-T) cell therapy, in relapsed/refractory multiple myeloma (RRMM)
    Jagannath, Sundar
    Berdeja, Jesus G.
    Jakubowiak, Andrzej
    Agha, Mounzer
    Cohen, Adam
    Madduri, Deepu
    Hari, Parameswaran
    Yeh, Tzu-Min
    Olyslager, Yunsi
    Banerjee, Arnob
    Jackson, Carolyn C.
    Allred, Alicia
    Zudaire, Enrique
    Deraedt, William
    Wu, Xiaoling
    Pacaud, Lida
    Akram, Muhammad
    Lin, Yi
    Martin, Thomas
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S15 - S16
  • [45] Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Have Received a Prior BCMA-Targeted Therapy: Real World, Multi-Institutional Experience
    Ferreri, Christopher J.
    Hildebrandt, Michelle A. T.
    Hashmi, Hamza
    Shune, Leyla O.
    McGuirk, Joseph P.
    Sborov, Douglas W.
    Wagner, Charlotte B.
    Kocoglu, M. Hakan
    Atrash, Shebli
    Voorhees, Peter M.
    Khouri, Jack
    Dima, Danai
    Afrough, Aimaz
    Sannareddy, Aishwarya
    Simmons, Gary
    Davis, James
    Kalariya, Nilesh
    Peres, Lauren C.
    Alsina, Melissa
    Locke, Frederick L.
    Sidana, Surbhi
    Hansen, Doris K.
    Patel, Krina
    Puglianini, Omar Alexis Castaneda
    BLOOD, 2022, 140 : 1856 - 1858
  • [46] Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011).
    Mailankody, Sham
    Jakubowiak, Andrzej J.
    Htut, Myo
    Costa, Luciano J.
    Lee, Kelvin
    Ganguly, Siddhartha
    Kaufman, Jonathan L.
    Siegel, David Samuel DiCapua
    Bensinger, William
    Cota, Mariana
    Doerr, Thomas
    DeVries, Todd
    Wong, Sandy Wai Kuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
  • [48] Increased Bone Turnover and Decreased BCMA Levels in Patients with Response to Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Ussmann, Jule
    Fischer, Luise
    Born, Patrick
    Grieb, Nora
    Hoffmann, Sandra
    Baber, Ronny
    Wang, Song-Yau
    Kloetzer, Christina
    Heyn, Simone
    Herling, Marco
    Herling, Carmen
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Hofbauer, Lorenz
    Platzbecker, Uwe
    Vucinic, Vladan
    Weidner, Heike
    Merz, Maximilian
    BLOOD, 2023, 142
  • [49] Efficacy and safety of elranatamab in pts with relapsed/ refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: a pooled analysis from MagnetisMM studies
    Raab, M. S.
    Hanel, M.
    Nooka, A. K.
    Lesokhin, A. M.
    Mohty, M.
    Niesvizky, R.
    Maisel, C.
    Arnulf, B.
    Larson, S. M.
    Varshavsky-Yanovsky, A. N.
    Leleu, X.
    Karlin, L.
    Vesole, D. H.
    Bahlis, N. J.
    de larrea, Fernandez C.
    Raje, N.
    Leip, E.
    Conte, U.
    Elmeliegy, M.
    Viqueira, A.
    Manier, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 232 - 232
  • [50] Efficacy and Safety of CAR-T Therapy with Safety Switch Targeting Bcma for Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Clinical Study
    Fu, Weijun, Sr.
    Du, Juan
    Jiang, Hua
    Cheng, Zhi
    Wei, Runhong
    Yu, Kang
    Jiang, Songfu
    He, Feng
    Fang, Hongliang
    Liu, Yarong
    Wang, Pin
    BLOOD, 2019, 134
12345